Medical Oncologist - Build a Community Cancer Program

Aoiassn; Laconia (NH); On-site; USD 350,000 - 500,000; Full time

Benefits offered by this job

Sign-on bonus

Relocation assistance

Retention bonus

Benefits package

Job summary

Concord Hospital Medical Group in the Lakes Region seeks two board-certified/board-eligible Medical Oncologists to help build a new medical oncology practice in Laconia, NH. You will collaborate with medical and radiation oncology teams to provide state-of-the-art cancer care close to home.

This CoC-accredited program offers involvement in tumor boards, quality initiatives, and clinical trials to advance oncology in Central New Hampshire.

Qualifications

• MD or DO from an accredited medical school.
• Fellowship training in Hematology/Oncology.
• Board-certified or board-eligible in Medical Oncology (ABIM).
• Eligible for licensure in the state of New Hampshire.
• Strong clinical, diagnostic, and patient-care skills.

Responsibilities

• Deliver comprehensive inpatient and outpatient care in medical oncology and hematology, including evaluation, treatment planning, and longitudinal follow-up.
• Collaborate with a multidisciplinary team to provide evidence-based, patient-centered cancer care.
• Participate in weekly multidisciplinary tumor boards and Cancer Committee initiatives.
• Contribute to program growth, quality improvement, and service line development within the Cancer Center.
• Engage in clinical trials and advance innovative oncology care.
• Demonstrate commitment to clinical excellence, professional growth, and patient advocacy.

Education

MD/DO

Hematology/Oncology fellowship

Job description

Concord Hospital Medical Group in the Lakes Region seeks two board-certified/board-eligible Medical Oncologists to help build a new medical oncology practice in Laconia, NH. You will collaborate with medical and radiation oncology teams to provide state-of-the-art cancer care close to home.

This CoC-accredited program offers involvement in tumor boards, quality initiatives, and clinical trials to advance oncology in Central New Hampshire.